Skip to main content

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Funding Notices

Displaying 61 - 70 of 505
Notice Announcement FOA Number Release Date Expiration date
Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications. NOT-EB-23-002
Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-24-022) NOT-EB-23-003
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) NOT-NS-23-035
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) NOT-NS-23-036
Notice of Early Expiration of NINDS BRAIN Initiative Notice of Funding Opportunity (NOFO) RFA-NS-21-026 and RFA-NS-21-027 NOT-NS-23-037
Notice of Technical Assistance Webinar for NOT-EB-22-001 - Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health NOT-EB-23-001
Notice of Change in Application Due Date for RFA-EB-21-001 NOT-EB-22-016
Notice of NIBIB Specific Interests and Guidance in RFA-NS-23-006 HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) NOT-EB-22-012
Notice of NIBIBs Withdrawal form Participation in RFA-HG-21-041 New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional). NOT-EB-22-014
Notice of NIBIB's Participation in PAR-22-181, " NCCIH, NEI, NIAAA, NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) NOT-EB-22-015